Home » interviews » Peptides are next frontline therapeutics led by GLP-1: Dr. Vandana Singh, Head - API Regulatory Sciences, Biocon Limited
Peptides are next frontline therapeutics led by GLP-1: Dr. Vandana Singh, Head - API Regulatory Sciences, Biocon Limited
Biocon is actively advancing in the peptide field, having already secured regulatory approvals for certain critical molecules, with a clear focus on GLP-1 analogs and other peptides
We use cookies to personalize content and ads, to provide social media
features and to analyze our traffic. We may also share information about
your use of our site with our social media, advertising and analytics
partners. If you continue to use our site, you consent to our use of
cookies as detailed in our updated
Privacy Policy
.
.png)
